An analytical study of Trastuzumab-dendrimer-fluorine drug delivery system in breast cancer therapy in vitro

Trastuzumab-dendrimer-fluorine drug delivery system

(2020) Dorota Bartusik-Aebisher   ACTA POLONIAE PHARMACEUTICA

Selected applications of fluorinated MR contrast agents and fluorine-containing drugs in medicine

(2020) Dorota Bartusik-Aebisher et al.   ACTA POLONIAE PHARMACEUTICA

MRI as a potential tool for monitoring of therapeutic monoclonal antibody distribution in cancer patients

(2020) Jacek Tabarkiewicz et al.   ACTA POLONIAE PHARMACEUTICA

Multicomponent Conjugates of Anticancer Drugs and Monoclonal Antibody with PAMAM Dendrimers to Increase Efficacy of HER-2 Positive Breast Cancer Therapy

(2019) Monika Marcinkowska et al.   PHARMACEUTICAL RESEARCH

Molecular Mechanisms of Antitumor Activity of PAMAM Dendrimer Conjugates with Anticancer Drugs and a Monoclonal Antibody

(2019) Marcinkowska et al.   Polymers

Conjugate of PAMAM Dendrimer, Doxorubicin and Monoclonal Antibody—Trastuzumab: The New Approach of a Well-Known Strategy

(2018) Monika Marcinkowska et al.   Polymers

Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium

(2018) Luca Falzone et al.   Frontiers in Pharmacology

Fluorine-19 MRI for detection and quantification of immune cell therapy for cancer

(2018) Fanny Chapelin et al.   Journal for ImmunoTherapy of Cancer

Paramagnetic fluorinated nanoemulsions for sensitive cellular fluorine-19 magnetic resonance imaging

(2016) Alexander A. Kislukhin et al.   NATURE MATERIALS

Dendrimer antibody conjugate to target and image HER-2 overexpressing cancer cells

(2016) James B. Otis et al.   Oncotarget

Trastuzumab-grafted PAMAM dendrimers for the selective delivery of anticancer drugs to HER2-positive breast cancer

(2016) Hitesh Kulhari et al.   Scientific Reports

19F applications in drug development and imaging – a review

(2014) Dorota Bartusik et al.   BIOMEDICINE & PHARMACOTHERAPY

Contrast agents for MRI: 30+ years and where are we going?

(2014) Valérie C. Pierre et al.   JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY

The immune system and response to HER2-targeted treatment in breast cancer

(2014) Giampaolo Bianchini et al.   LANCET ONCOLOGY

Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI

(2014) Eric T. Ahrens et al.   MAGNETIC RESONANCE IN MEDICINE

Detection of 19F-labeled biopharmaceuticals in cell cultures with magnetic resonance

(2013) Dorota Bartusik et al.   ADVANCED DRUG DELIVERY REVIEWS

19F MRI detection of acute allograft rejection with in vivo perfluorocarbon labeling of immune cells

(2011) T. Kevin Hitchens et al.   MAGNETIC RESONANCE IN MEDICINE

Ex vivo assays of CEM cells cultured and treated in the three dimensional cultures

(2010) Dorota Bartusik et al.   BIOMEDICINE & PHARMACOTHERAPY

19F MRI for quantitative in vivo cell tracking

(2010) Mangala Srinivas et al.   TRENDS IN BIOTECHNOLOGY

Application of 19F magnetic resonance to study the efficacy of fluorine labeled drugs in the three-dimensional cultured breast cancer cells

(2009) Dorota Bartusik et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Detection of fluorine labeled Herceptin using cellular 19F MRI ex vivo

(2009) Dorota Bartusik et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Fluorine-containing nanoemulsions for MRI cell tracking

(2009) Jelena M. Janjic et al.   Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology